Received May 5, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | Z010609 | — |
No other AE; product being administered after a temperature excursion.; This spontaneous report was received from a other health professional, concerning to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the vaccine with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) experienced a temperature excursion (TE) for 1 hour and 30 minutes at 35.74F. On 27-Apr-2026, the patient was vaccinated with a vaccine involved in the TE: Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB), (lot #Z010609 has been verified to be valid, expiration date reported and confirmed 31-Mar-2028) 0.5 mL, as prophylaxis (route not provided). No adverse event (No adverse event).